Biography and Research Information
OverviewAI-generated summary
D. Bae's research focuses on outcomes and specific treatments within cardiology, particularly in the context of heart transplantation and mechanical circulatory support. Recent publications investigate the efficacy of Letermovir for cytomegalovirus (CMV) prophylaxis in heart transplant recipients and the characteristics of recipients who contracted Coronavirus Disease 2019 (COVID-19). Other studies examine electrocardiographic markers for myocardial recovery in patients with left ventricular assist devices (LVADs) and access-site complications post-transplant. Additionally, Bae has explored the impact of certain medications, such as Belatacept, on donor-specific antibodies in heart transplant recipients and the role of cardiac papillary fibroelastoma in cryptogenic stroke. Collaborations include shared publications with Sahil Sabharwal, Sarah Assem, and Eun‐Jung Bae.
Metrics
- h-index: 1
- Publications: 22
- Citations: 4
Selected Publications
-
Cardiac papillary fibroelastoma and cryptogenic stroke: a diagnostic and therapeutic challenge (2025)
Collaboration Network
Top Collaborators
J. Baranowska
Columbia University Irving Medical Center (US)
15 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
- Does Pacemaker Mode Affect Outcomes in Patients with Heartmate 3 LVAD?
Showing 5 of 15 shared publications
A. Fernandez Valledor
Cornell University (US)
14 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
- It’s Complicated: Cumulative Complication Rates during Temporary Mechanical Circulatory Support and Heart Transplant Outcomes
Showing 5 of 14 shared publications
B. Elad
Columbia University Irving Medical Center (US)
13 shared publications
- Does Pacemaker Mode Affect Outcomes in Patients with Heartmate 3 LVAD?
- Epidemiology, Treatment and Outcomes of Prostate Cancer in Heart Transplant Recipients
- It’s Complicated: Cumulative Complication Rates during Temporary Mechanical Circulatory Support and Heart Transplant Outcomes
- Temporary Mechanical Circulatory Support Related Complications in Patients Waiting for Heart Transplant
- Life After Temporary Mechanical Circulatory Support: Device Specific Post-Transplant Outcomes
Showing 5 of 13 shared publications
J. Fried
Columbia University Irving Medical Center (US)
10 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
- Does Pacemaker Mode Affect Outcomes in Patients with Heartmate 3 LVAD?
Showing 5 of 10 shared publications
Shamima Rahman
Columbia University Irving Medical Center (US)
9 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Epidemiology, Treatment and Outcomes of Prostate Cancer in Heart Transplant Recipients
- It’s Complicated: Cumulative Complication Rates during Temporary Mechanical Circulatory Support and Heart Transplant Outcomes
Showing 5 of 9 shared publications
D. Majure
Cornell University (US)
8 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronarvirus Disease 2019 Who Received Casirivimab Plus Imdevimab Infusion
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
Showing 5 of 8 shared publications
F. Latif
Columbia University Irving Medical Center (US)
8 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Heart Transplantation in a Patient with Active Thyroid Cancer
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
Showing 5 of 8 shared publications
Gabriel Sayer
Columbia University Irving Medical Center (US)
8 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Heart Transplantation in a Patient with Active Thyroid Cancer
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
Showing 5 of 8 shared publications
D. Lotan
Columbia University Irving Medical Center (US)
7 shared publications
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronarvirus Disease 2019 Who Received Casirivimab Plus Imdevimab Infusion
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- It’s Complicated: Cumulative Complication Rates during Temporary Mechanical Circulatory Support and Heart Transplant Outcomes
- Temporary Mechanical Circulatory Support Related Complications in Patients Waiting for Heart Transplant
- Life After Temporary Mechanical Circulatory Support: Device Specific Post-Transplant Outcomes
Showing 5 of 7 shared publications
Matthew Regan
Columbia University Irving Medical Center (US)
7 shared publications
- Epidemiology, Treatment and Outcomes of Prostate Cancer in Heart Transplant Recipients
- It’s Complicated: Cumulative Complication Rates during Temporary Mechanical Circulatory Support and Heart Transplant Outcomes
- Temporary Mechanical Circulatory Support Related Complications in Patients Waiting for Heart Transplant
- Use of Belatacept in Heart Transplant Recipients - Rejection Rates and Mortality
- Rates of Viremia Before and After Initiation of Belatacept Therapy in Heart Transplant Recipients
Showing 5 of 7 shared publications
K. Oh
Columbia University Irving Medical Center (US)
6 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Heart Transplantation in a Patient with Active Thyroid Cancer
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Does Pacemaker Mode Affect Outcomes in Patients with Heartmate 3 LVAD?
- Temporary Mechanical Circulatory Support Related Complications in Patients Waiting for Heart Transplant
Showing 5 of 6 shared publications
Nir Uriel
Columbia University Irving Medical Center (US)
6 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Heart Transplantation in a Patient with Active Thyroid Cancer
- Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
Showing 5 of 6 shared publications
Kevin J. Clerkin
Columbia University Irving Medical Center (US)
6 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
- Use of Belatacept in Heart Transplant Recipients - Rejection Rates and Mortality
- Association Between Peripheral Artery Disease and Outcomes Following Heart Transplantation
Showing 5 of 6 shared publications
J. Raikhelkar
Columbia University Irving Medical Center (US)
5 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Heart Transplantation in a Patient with Active Thyroid Cancer
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
- Use of Belatacept in Heart Transplant Recipients - Rejection Rates and Mortality
C.M. Moeller
Columbia University Irving Medical Center (US)
5 shared publications
- Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
- Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
- Use of Belatacept in Heart Transplant Recipients - Rejection Rates and Mortality
- Impact of Heart Failure GDMT on Hemocompatibility Related Adverse Events in Heart Mate 3 Recipients
- The Molecular Microscope Detects Antibody-Mediated Rejection Regardless of Donor-Specific Antibody Median Fluorescence Intensity
Similar Researchers
Based on overlapping research topics
Amy Dossey
University of Arkansas for Medical Sciences
Organ Transplantation Techniques and Outcomes
Mechanical Circulatory Support Devices
Cardiovascular Function and Risk Factors
Raj Patel
University of Arkansas for Medical Sciences
Organ Transplantation Techniques and Outcomes
Microbial infections and disease research
SARS-CoV-2 and COVID-19 Research
Amairani Paredes
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Microbial infections and disease research
SARS-CoV-2 and COVID-19 Research
Amna Qasim
University of Arkansas for Medical Sciences
Organ Transplantation Techniques and Outcomes
Cardiovascular Function and Risk Factors
SARS-CoV-2 and COVID-19 Research
Rajani Jagana
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Microbial infections and disease research
SARS-CoV-2 and COVID-19 Research
Abraham Reddy
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Microbial infections and disease research
SARS-CoV-2 and COVID-19 Research